When is Innovacell Inc's IPO?

Innovacell Inc's IPO is currently expected around Feb 24, 2026 on JPX Growth. IPO dates can move until the company files and prices the offering, so we keep this page updated as new details are confirmed.

What is Innovacell Inc's expected IPO price?

Innovacell Inc's expected IPO price is $8.37 per share.

Is Innovacell Inc publicly traded?

Not yet — Innovacell Inc is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Innovacell Inc's pre-IPO price and IPO date will appear here as soon as they're available.

All companies

Innovacell Inc

504A

IPO Upcoming

IPO UpcomingJapan(JPX Growth)0 markets

Official IPO

Priced· JPX Growth· Listing market: Japan

IPO date

Feb 24, 2026

Final IPO price

$8.37

Shares offered

To be announced

IPO raise

To be announced

Sources: jpx

No live market is quoted for Innovacell Inc yet. Get in line for IPO-day access through a broker in the meantime.

eToro

Invest in stocks once they list with eToro

Trade stocks, ETFs and crypto from one simple account.

Start with eToro

About Innovacell Inc

Innovacell Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.

What the company does

Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.

Business profile

Innovacell Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.

Latest Innovacell Inc IPO news

Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.

Innovacell’s ICEF15 nears final stage of patient enrollment in multi-regional clinical trial; initiatives for Global Aggregation Model ramp up

ログミーファイナンス (Logmi Finance)Jun 5, 2026IPO context

Logmi Finance published an English Q1 FY2026 financial results briefing dated 2026-06-05, describing Innovacell’s progress after its February 24, 2026 TSE Growth listing, including ICEF15 multi-regional Phase III enrollment nearing final stages and related pipeline/global aggregation initiatives.

譲渡制限付株式報酬としての新株式の発行の払込完了に関するお知らせ（2026/05/22 15:30提出）

IRBANKMay 22, 2026IPO context

Innovacell (504A) disclosed that the subscription/payment for newly issued shares issued as restricted stock compensation was completed, with the filing submitted on May 22, 2026 at 15:30 JST.

Innovacell (504A) News: 2026年12月期第1四半期事業進捗説明動画配信のお知らせ

イノバセル株式会社 (Innovacell Inc.)May 13, 2026IPO context

Innovacell’s IR news page lists a 2026-05-13 announcement for releasing a video on Q1 FY2026 business progress for the year ending 2026-12, providing a post-IPO operational update.

Innovacell Inc IPO — frequently asked questions

When is Innovacell Inc's IPO?: Innovacell Inc's IPO is currently expected around Feb 24, 2026 on JPX Growth. IPO dates can move until the company files and prices the offering, so we keep this page updated as new details are confirmed.
What is Innovacell Inc's expected IPO price?: Innovacell Inc's expected IPO price is $8.37 per share.
Is Innovacell Inc publicly traded?: Not yet — Innovacell Inc is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Innovacell Inc's pre-IPO price and IPO date will appear here as soon as they're available.